Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management

Endocrine tumors comprise a range of benign and malignant conditions that produce a spectrum of clinical symptoms and signs depending on the specific hormones they produce. The symptoms and presentations of these tumors are often independent of their size and location. Because of their expression of...

Full description

Saved in:
Bibliographic Details
Published in:Journal of endocrinological investigation 2010-01, Vol.33 (1), p.54-60
Main Authors: Naji, M, Hodolic, M, El-Refai, S, Khan, S, Marzola, M C, Rubello, D, Al-Nahhas, A
Format: Article
Language:English
Subjects:
Adrenal Gland Neoplasms - diagnostic imaging
Adrenal Medulla - metabolism
Carcinoma, Neuroendocrine - diagnostic imaging
Catecholamines
Cushing Syndrome - etiology
Endocrine Gland Neoplasms - diagnostic imaging
Fluorodeoxyglucose F18
Humans
Organometallic Compounds
Parathyroid Neoplasms - diagnostic imaging
Pituitary Neoplasms - diagnostic imaging
Positron-Emission Tomography - methods
Radiopharmaceuticals
Receptors, Somatostatin - analysis
Thyroid Neoplasms - diagnostic imaging
Tomography, X-Ray Computed - methods
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Endocrine tumors comprise a range of benign and malignant conditions that produce a spectrum of clinical symptoms and signs depending on the specific hormones they produce. The symptoms and presentations of these tumors are often independent of their size and location. Because of their expression of cell membrane receptors or production of specific types of hormones or peptides, endocrine tumors can be identified with functional radionuclide imaging much more readily compared to standard cross-sectional imaging. In recent years, 18F-fluoro-deoxy- D-glucose positron emission tomography (18F-FDG-PET) has emerged as a useful tool for diagnosing and assessing many tumors. In this review we describe how PET, using 18F-FDG and other radiopharmaceuticals can be useful in the diagnosis and management of a wide range of endocrine tumors.
ISSN:1720-8386
DOI:10.3275/6561